The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis
Open accessAbstract
Background: In individual studies and limited meta-analyses venlafaxine has been reported to be more effective than comparator antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs). Aims: To perform a systematic review of all such studies. Method: We conducted a systematic review of double-blind, randomised trials comparing venlafaxine with alternative antidepressants in the treatment of depression. The primary outcome was the difference in final depression rating scale value, expressed as a standardised effect size. Secondary outcomes were response rate, remission rate and tolerability. Results: A total of 32 randomised trials were included. Venlafaxine was more effective than other antidepressants (standardised effect size was −0.14, 95% Cl −0.07 to −0.22). A similar significant advantage was found against SSRIs (20 studies) but nottricyclic antidepressants (7 studies). Conclusions: Venlafaxine has greater efficacy than SSRIs although there is uncertainty in comparison with other antidepressants. Further studies are required to determine the clinical importance of this finding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1976) · Medical Entomology and Zoology · Cited by 8,899
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Self-citationAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Self-citationPharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Self-citationRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
Heninger, G., Delgado, P., & Charney, D. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979535 · Cited by 380
Venlafaxine: A Review of its Pharmacology and Therapeutic Potential in Depression
Holliday, S. M., & Benfield, P. (1995) · Drugs · doi:10.2165/00003495-199549020-00010 · Cited by 327
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
Mace, S., & Taylor, D. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315
Nelson, J. C. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280019002 · Cited by 294
Silverstone, P. H., Ravindran, A., & the Venlafaxine XR 360 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0105 · Cited by 246
Barbui, C., & Hotopf, M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.129 · Cited by 182
Venlafaxine and paroxetine in treatment-resistant depression
Gregson, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.6.591a · Cited by 171
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
CUNNINGHAM, L. A., BORISON, R. L., CARMAN, J. S., CHOUINARD, G., CROWDER, J. E., DIAMOND, B. I., FISCHER, D. E., & HEARST, E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00003 · Cited by 159
Rudolph, R. L., & Feiger, A. D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00067-1 · Cited by 158
Dieric, M., Ravizza, U., Realini, R., & Martin, A. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00292-8 · Cited by 152
Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression
Zanardi, R., Franchini, L., Serretti, A., Pérez, J., & Smeraldi, E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0107 · Cited by 134
Rudolph, R. L., Fabre, L. F., Feighner, J. P., Rickels, K., Entsuah, R., & Derivan, A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0305 · Cited by 132
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer, E. E., Feighner, J. P., Mandos, L. A., & Rickels, K. (1994) · PubMed · Cited by 128
Combination Treatment with Noradrenalin and Serotonin Reuptake Inhibitors in Resistant Depression
Seth, R., Jennings, A. L., Bindman, J., Phillips, J., & Bergmann, K. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.4.562 · Cited by 125
Freemantle, N., Anderson, I. M., & Young, P. J. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.4.292 · Cited by 121
Self-citationBenkert, O., Gründer, G., Wetzel, H., & Hackett, D. (1996) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00029-5 · Cited by 105
Mehtonen, O. ‐., Søgaard, J., Roponen, P., Behnke, K., & Venlafaxine 631 Study Group (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0204 · Cited by 97
Silva, J. C. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0703 · Cited by 95
Tzanakaki, M., Guazzelli, M., Nimatoudis, I., & Zissis, N. P. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015010-00004 · Cited by 80
Partial remission in depressive disorders
Cornwall, P. L., & Scott, J. L. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09630.x · Cited by 77
Shrivastava, R. K., Cohn, C., Crowder, J., Davidson, J. R. T., Dünner, D. L., Feighner, J. P., Kiev, A., & Patrick, R. (1994) · PubMed · Cited by 76
Efficacy of venlafaxine in depressive illness in general practice
Lecrubier, Y., Bourin, M., Moon, C. A. L., Schifano, F., Blanchard, C., Danjou, P., & Hackett, D. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb10136.x · Cited by 75
Ballús, C., Quiros, G., de Flores, T., de la Torre, J., Palao, D. J., Rojo, L., Gutiérrez, M., Casais, L., & Riesgo, Y. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015010-00007 · Cited by 65
Treatment of major depression: Is improvement enough?
Ferrier, I. N. (1999) · PubMed · doi:10.25405/ncl.34642788 · Cited by 59
Abdelmawla, Langley, Szabadi, & Bradshaw (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00031.x · Cited by 58
Mahapatra, S., & Hackett, D. (1997) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1997.tb11434.x · Cited by 58
Eccles, M., Freemantle, N., & Mason, J. (1999) · Family Practice · doi:10.1093/fampra/16.2.103 · Cited by 55
Self-citationSelective serotonin reuptake inhibitors.
Edwards, J. G. (1992) · BMJ · doi:10.1136/bmj.304.6843.1644 · Cited by 50
Dose-Response Relationship With Venlafaxine
Kelsey, J. E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00005 · Cited by 49
Bias in the Analysis and Reporting of Randomized Controlled Trials
Stewart, L. A., & Parmar, M. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009612 · Cited by 42
Gentil, V., Kerr-Corrêa, F., Moreno, R. A., Busnello, E. D., Campos, J. A. D. O., Juruena, M. F., Lafer, B., Moreno, D. H., Rosa, L. D. C. R., Tiosso, A., et al. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400108 · Cited by 37
Efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression
Figueira, M. L., Arriaga, F., Lara, E., Albuquerque, A. J., & Gamito, L. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)80184-3 · Cited by 33
McPartlin, G., Reynolds, A., Anderson, C. C., Casoy, J., & Boyd, M. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)88532-x · Cited by 33
Samuelian, J., & Hackett, D. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200307 · Cited by 26
Samuelian, J., Tatossian, A., & Hackett, D. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199202001-00627 · Cited by 11
Venlafaxine versus fluoxetine in the treatment of depressed patients with concomitant anxiety
Geerts, S., Lacante, P., & Mignon, A. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)80156-4 · Cited by 5
Cited by
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Self-citationCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citationBrent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., et al. (2008) · JAMA · doi:10.1001/jama.299.8.901 · Cited by 700
Metadata
- Authors
- Smith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2002-05
- Volume
- 180
- Issue
- 5
- Pages
- 396-404
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2141398558
- Cited by
- 538
- References
- 49
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.